

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.39955690 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.39955690 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.77410489 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.72372452 |
| 5 | * cellular response to type I interferon (GO:0071357) | 5.65999005 |
| 6 | * type I interferon signaling pathway (GO:0060337) | 5.65999005 |
| 7 | * response to type I interferon (GO:0034340) | 5.65884510 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.41086071 |
| 9 | negative regulation of cell killing (GO:0031342) | 5.41086071 |
| 10 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 5.14492449 |
| 11 | positive regulation of interferon-alpha production (GO:0032727) | 5.10995697 |
| 12 | regulation of interferon-alpha production (GO:0032647) | 4.81277913 |
| 13 | response to interferon-alpha (GO:0035455) | 4.76206042 |
| 14 | negative regulation of interleukin-12 production (GO:0032695) | 4.52550155 |
| 15 | cellular response to interferon-beta (GO:0035458) | 4.51372608 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.36968407 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 4.28893076 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 4.28893076 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.28893076 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.28893076 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.28893076 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 4.28893076 |
| 23 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 4.25411074 |
| 24 | response to interferon-beta (GO:0035456) | 4.24795237 |
| 25 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.22459000 |
| 26 | cellular response to interferon-alpha (GO:0035457) | 4.19398723 |
| 27 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.16875067 |
| 28 | negative regulation of viral genome replication (GO:0045071) | 4.09648606 |
| 29 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 4.07259151 |
| 30 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.04788764 |
| 31 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.98572900 |
| 32 | immunoglobulin mediated immune response (GO:0016064) | 3.97601652 |
| 33 | detection of other organism (GO:0098543) | 3.97373367 |
| 34 | T-helper 1 type immune response (GO:0042088) | 3.95960233 |
| 35 | regulation of RIG-I signaling pathway (GO:0039535) | 3.95376980 |
| 36 | defense response to protozoan (GO:0042832) | 3.90496063 |
| 37 | response to peptidoglycan (GO:0032494) | 3.89824852 |
| 38 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.89320736 |
| 39 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.88831095 |
| 40 | natural killer cell mediated immunity (GO:0002228) | 3.88831095 |
| 41 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.87572970 |
| 42 | regulation of T cell tolerance induction (GO:0002664) | 3.86620867 |
| 43 | neutrophil activation involved in immune response (GO:0002283) | 3.84428112 |
| 44 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.84382757 |
| 45 | detection of molecule of bacterial origin (GO:0032490) | 3.84038572 |
| 46 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.83332571 |
| 47 | myeloid dendritic cell differentiation (GO:0043011) | 3.78488319 |
| 48 | positive regulation of antigen processing and presentation (GO:0002579) | 3.77695104 |
| 49 | positive regulation of interferon-beta production (GO:0032728) | 3.75629190 |
| 50 | T cell migration (GO:0072678) | 3.74198827 |
| 51 | detection of bacterium (GO:0016045) | 3.71460146 |
| 52 | response to interleukin-15 (GO:0070672) | 3.64027306 |
| 53 | detection of external biotic stimulus (GO:0098581) | 3.60738618 |
| 54 | leukocyte aggregation (GO:0070486) | 3.60320061 |
| 55 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.59059013 |
| 56 | positive regulation of interleukin-12 production (GO:0032735) | 3.58741040 |
| 57 | * cellular response to interferon-gamma (GO:0071346) | 3.57901406 |
| 58 | regulation of tolerance induction (GO:0002643) | 3.55218531 |
| 59 | response to protozoan (GO:0001562) | 3.54349552 |
| 60 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.53713192 |
| 61 | myeloid dendritic cell activation (GO:0001773) | 3.52222240 |
| 62 | negative regulation of T cell mediated immunity (GO:0002710) | 3.51153266 |
| 63 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.50642497 |
| 64 | regulation of regulatory T cell differentiation (GO:0045589) | 3.47170170 |
| 65 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.43829418 |
| 66 | cellular response to interleukin-15 (GO:0071350) | 3.43602890 |
| 67 | positive regulation of tolerance induction (GO:0002645) | 3.42086369 |
| 68 | positive regulation of type 2 immune response (GO:0002830) | 3.39990657 |
| 69 | positive regulation of humoral immune response (GO:0002922) | 3.38924813 |
| 70 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.38626588 |
| 71 | cellular response to virus (GO:0098586) | 3.37782337 |
| 72 | defense response to virus (GO:0051607) | 3.35815225 |
| 73 | NIK/NF-kappaB signaling (GO:0038061) | 3.35736165 |
| 74 | regulation of immunoglobulin secretion (GO:0051023) | 3.34529681 |
| 75 | regulation of antigen processing and presentation (GO:0002577) | 3.32469811 |
| 76 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.32408804 |
| 77 | response to host immune response (GO:0052572) | 3.32383646 |
| 78 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.32383646 |
| 79 | microglial cell activation (GO:0001774) | 3.29015401 |
| 80 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.27896098 |
| 81 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.26893780 |
| 82 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.24502111 |
| 83 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.24255138 |
| 84 | respiratory burst (GO:0045730) | 3.23500190 |
| 85 | * response to interferon-gamma (GO:0034341) | 3.23478295 |
| 86 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.23334839 |
| 87 | germinal center formation (GO:0002467) | 3.21105138 |
| 88 | regulation of response to interferon-gamma (GO:0060330) | 3.19763227 |
| 89 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.19715349 |
| 90 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.19489321 |
| 91 | positive regulation of T cell cytokine production (GO:0002726) | 3.19477552 |
| 92 | positive thymic T cell selection (GO:0045059) | 3.18992363 |
| 93 | detection of biotic stimulus (GO:0009595) | 3.18978242 |
| 94 | lymphocyte chemotaxis (GO:0048247) | 3.18245064 |
| 95 | macrophage activation involved in immune response (GO:0002281) | 3.17004688 |
| 96 | B cell mediated immunity (GO:0019724) | 3.16656051 |
| 97 | cellular response to exogenous dsRNA (GO:0071360) | 3.14779126 |
| 98 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.13129129 |
| 99 | macrophage activation (GO:0042116) | 3.12855012 |
| 100 | negative thymic T cell selection (GO:0045060) | 3.12423847 |
| 101 | regulation of chemokine biosynthetic process (GO:0045073) | 3.12167811 |
| 102 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.11172389 |
| 103 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.10993683 |
| 104 | cellular extravasation (GO:0045123) | 3.10973367 |
| 105 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.10479319 |
| 106 | myeloid cell activation involved in immune response (GO:0002275) | 3.09169928 |
| 107 | tolerance induction (GO:0002507) | 3.09011407 |
| 108 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.08056116 |
| 109 | granulocyte activation (GO:0036230) | 3.06573272 |
| 110 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.06220357 |
| 111 | positive regulation of interleukin-17 production (GO:0032740) | 3.03307763 |
| 112 | regulation of gamma-delta T cell activation (GO:0046643) | 3.01905659 |
| 113 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.01819947 |
| 114 | response to muramyl dipeptide (GO:0032495) | 3.01591259 |
| 115 | regulation of memory T cell differentiation (GO:0043380) | 3.01559843 |
| 116 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.01478692 |
| 117 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.01478692 |
| 118 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.00841888 |
| 119 | regulation of interleukin-12 production (GO:0032655) | 3.00749405 |
| 120 | positive regulation of defense response to virus by host (GO:0002230) | 3.00093337 |
| 121 | response to host (GO:0075136) | 2.99700745 |
| 122 | response to host defenses (GO:0052200) | 2.99700745 |
| 123 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.99700745 |
| 124 | positive regulation of interleukin-2 production (GO:0032743) | 2.98903962 |
| 125 | negative T cell selection (GO:0043383) | 2.97976644 |
| 126 | regulation of T-helper 1 type immune response (GO:0002825) | 2.97238675 |
| 127 | neutrophil activation (GO:0042119) | 2.96504694 |
| 128 | regulation of T-helper cell differentiation (GO:0045622) | 2.96450059 |
| 129 | regulation of hypersensitivity (GO:0002883) | 2.95823165 |
| 130 | dendritic cell differentiation (GO:0097028) | 2.95206199 |
| 131 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.92268233 |
| 132 | positive regulation of response to biotic stimulus (GO:0002833) | 2.92177282 |
| 133 | positive T cell selection (GO:0043368) | 2.89322434 |
| 134 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.87578827 |
| 135 | negative regulation of innate immune response (GO:0045824) | 2.86635994 |
| 136 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.85181452 |
| 137 | T cell selection (GO:0045058) | 2.80665802 |
| 138 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.79305606 |
| 139 | positive regulation of B cell differentiation (GO:0045579) | 2.78985786 |
| 140 | interferon-gamma production (GO:0032609) | 2.78299322 |
| 141 | regulation of B cell differentiation (GO:0045577) | 2.77280129 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.15359658 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 7.04380253 |
| 3 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.61524636 |
| 4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.37536797 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.98481294 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.70500966 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.02074569 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.66618002 |
| 9 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.41286422 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.32970755 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.32279252 |
| 12 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.17304232 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.04565126 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.94406069 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.73336443 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.49966964 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.34983853 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.34136902 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.33914580 |
| 20 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.24590774 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.20161768 |
| 22 | * MYB_26560356_Chip-Seq_TH2_Human | 2.02734960 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 1.91937260 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.89336333 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.84141638 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.83209069 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.80901825 |
| 28 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77792837 |
| 29 | * MYB_26560356_Chip-Seq_TH1_Human | 1.65709731 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.62713739 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62273220 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.56100732 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51567498 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51220581 |
| 35 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.48863966 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.48547700 |
| 37 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45740064 |
| 38 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42969502 |
| 39 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40853812 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39263050 |
| 41 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.36827292 |
| 42 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.33364932 |
| 43 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.32367299 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.31961019 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.30424935 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30341752 |
| 47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.27096333 |
| 48 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24734945 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.24588336 |
| 50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.20556617 |
| 51 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.17970398 |
| 52 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17233985 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15882698 |
| 54 | * MAF_26560356_Chip-Seq_TH2_Human | 1.15267951 |
| 55 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14742753 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12919761 |
| 57 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12381088 |
| 58 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06792759 |
| 59 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06722483 |
| 60 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04303561 |
| 61 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02940746 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.01840490 |
| 63 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01575344 |
| 64 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99811372 |
| 65 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99195194 |
| 66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97732767 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.97157753 |
| 68 | * EGR1_19032775_ChIP-ChIP_M12_Human | 0.97156450 |
| 69 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96869773 |
| 70 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96630898 |
| 71 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92707855 |
| 72 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.92281817 |
| 73 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91338954 |
| 74 | MYC_22102868_ChIP-Seq_BL_Human | 0.90292638 |
| 75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89572105 |
| 76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86053548 |
| 77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85831655 |
| 78 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.82981783 |
| 79 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.80961838 |
| 80 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.78359408 |
| 81 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77398310 |
| 82 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.77212416 |
| 83 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.77111679 |
| 84 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.75430191 |
| 85 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.74676089 |
| 86 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73729437 |
| 87 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.73490681 |
| 88 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.72420077 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.72030370 |
| 90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.71822431 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.71634275 |
| 92 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.71221181 |
| 93 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.71200746 |
| 94 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.71111012 |
| 95 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.70674940 |
| 96 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.70176246 |
| 97 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.70176246 |
| 98 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.70094427 |
| 99 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.69693534 |
| 100 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.68458104 |
| 101 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.68383706 |
| 102 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.66556890 |
| 103 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.66119461 |
| 104 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.65958582 |
| 105 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.64968185 |
| 106 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64376866 |
| 107 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.63961470 |
| 108 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.58626885 |
| 109 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.58595528 |
| 110 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.58141076 |
| 111 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.57355942 |
| 112 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57222962 |
| 113 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.57090204 |
| 114 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.56426878 |
| 115 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.56375896 |
| 116 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.55571535 |
| 117 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.53093706 |
| 118 | GATA2_19941826_ChIP-Seq_K562_Human | 0.52560604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.02130188 |
| 2 | MP0009785_altered_susceptibility_to | 4.33201729 |
| 3 | MP0003436_decreased_susceptibility_to | 3.49658438 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.44479664 |
| 5 | MP0000685_abnormal_immune_system | 3.43032539 |
| 6 | MP0005671_abnormal_response_to | 3.25846856 |
| 7 | MP0003724_increased_susceptibility_to | 3.22477522 |
| 8 | MP0005025_abnormal_response_to | 3.22075915 |
| 9 | MP0005387_immune_system_phenotype | 3.21756211 |
| 10 | MP0001790_abnormal_immune_system | 3.21756211 |
| 11 | MP0005000_abnormal_immune_tolerance | 3.15581176 |
| 12 | MP0006082_CNS_inflammation | 3.11417253 |
| 13 | MP0004510_myositis | 3.09544592 |
| 14 | MP0001800_abnormal_humoral_immune | 2.77689881 |
| 15 | MP0003303_peritoneal_inflammation | 2.74010953 |
| 16 | MP0002419_abnormal_innate_immunity | 2.72943420 |
| 17 | MP0002723_abnormal_immune_serum | 2.68428408 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.67053819 |
| 19 | MP0002006_tumorigenesis | 2.46433877 |
| 20 | MP0001819_abnormal_immune_cell | 2.35790639 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.35148100 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.30819260 |
| 23 | MP0004947_skin_inflammation | 2.28420592 |
| 24 | MP0001853_heart_inflammation | 1.97144972 |
| 25 | MP0001533_abnormal_skeleton_physiology | 1.94080803 |
| 26 | MP0003448_altered_tumor_morphology | 1.91453807 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.91018360 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.87056341 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.84208031 |
| 30 | MP0002405_respiratory_system_inflammati | 1.84141323 |
| 31 | MP0009764_decreased_sensitivity_to | 1.84075255 |
| 32 | MP0003763_abnormal_thymus_physiology | 1.83693668 |
| 33 | MP0000716_abnormal_immune_system | 1.78284546 |
| 34 | MP0002398_abnormal_bone_marrow | 1.77592344 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.73612230 |
| 36 | MP0008469_abnormal_protein_level | 1.73535181 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.70564125 |
| 38 | MP0005451_abnormal_body_composition | 1.63661081 |
| 39 | MP0005310_abnormal_salivary_gland | 1.57073814 |
| 40 | MP0008260_abnormal_autophagy | 1.55772935 |
| 41 | MP0000343_altered_response_to | 1.52185586 |
| 42 | MP0003075_altered_response_to | 1.48761445 |
| 43 | MP0002429_abnormal_blood_cell | 1.41972799 |
| 44 | MP0000858_altered_metastatic_potential | 1.38400308 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.37279349 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.35371643 |
| 47 | MP0002998_abnormal_bone_remodeling | 1.31799700 |
| 48 | MP0002722_abnormal_immune_system | 1.30637532 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.25738960 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.25738960 |
| 51 | MP0004782_abnormal_surfactant_physiolog | 1.23523527 |
| 52 | MP0000604_amyloidosis | 1.22288030 |
| 53 | MP0009278_abnormal_bone_marrow | 1.21428299 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.18894635 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 1.17078650 |
| 56 | MP0004883_abnormal_blood_vessel | 1.14861452 |
| 57 | MP0008004_abnormal_stomach_pH | 1.13919663 |
| 58 | MP0005166_decreased_susceptibility_to | 1.10986949 |
| 59 | MP0009840_abnormal_foam_cell | 1.08565844 |
| 60 | MP0004808_abnormal_hematopoietic_stem | 1.08453070 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.06450374 |
| 62 | MP0009763_increased_sensitivity_to | 1.04342187 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.03967630 |
| 64 | MP0010307_abnormal_tumor_latency | 1.03637351 |
| 65 | MP0003866_abnormal_defecation | 0.98443015 |
| 66 | MP0002132_abnormal_respiratory_system | 0.95468922 |
| 67 | MP0005164_abnormal_response_to | 0.95216188 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 0.95204380 |
| 69 | MP0001663_abnormal_digestive_system | 0.93720539 |
| 70 | MP0002933_joint_inflammation | 0.93437289 |
| 71 | MP0001851_eye_inflammation | 0.92363069 |
| 72 | MP0004381_abnormal_hair_follicle | 0.92331484 |
| 73 | MP0000703_abnormal_thymus_morphology | 0.92240426 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 0.91906468 |
| 75 | MP0002254_reproductive_system_inflammat | 0.91886805 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 0.90497485 |
| 77 | MP0003091_abnormal_cell_migration | 0.90057526 |
| 78 | MP0004858_abnormal_nervous_system | 0.90011376 |
| 79 | MP0003186_abnormal_redox_activity | 0.89374773 |
| 80 | MP0003806_abnormal_nucleotide_metabolis | 0.88906197 |
| 81 | MP0005390_skeleton_phenotype | 0.87975177 |
| 82 | MP0003566_abnormal_cell_adhesion | 0.83670156 |
| 83 | MP0001873_stomach_inflammation | 0.83509599 |
| 84 | MP0003690_abnormal_glial_cell | 0.82297638 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 0.81382108 |
| 86 | MP0002139_abnormal_hepatobiliary_system | 0.80409675 |
| 87 | MP0003045_fibrosis | 0.78959132 |
| 88 | MP0000249_abnormal_blood_vessel | 0.78300869 |
| 89 | MP0003828_pulmonary_edema | 0.78019803 |
| 90 | MP0006054_spinal_hemorrhage | 0.75952609 |
| 91 | MP0001881_abnormal_mammary_gland | 0.74387237 |
| 92 | MP0002396_abnormal_hematopoietic_system | 0.73849737 |
| 93 | MP0001348_abnormal_lacrimal_gland | 0.72913066 |
| 94 | MP0010352_gastrointestinal_tract_polyps | 0.72315042 |
| 95 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70415038 |
| 96 | MP0005023_abnormal_wound_healing | 0.69815099 |
| 97 | MP0003705_abnormal_hypodermis_morpholog | 0.66574991 |
| 98 | MP0002136_abnormal_kidney_physiology | 0.65365164 |
| 99 | MP0000569_abnormal_digit_pigmentation | 0.63268666 |
| 100 | MP0002332_abnormal_exercise_endurance | 0.61052487 |
| 101 | MP0008438_abnormal_cutaneous_collagen | 0.60934774 |
| 102 | MP0008874_decreased_physiological_sensi | 0.60666002 |
| 103 | MP0005076_abnormal_cell_differentiation | 0.58863989 |
| 104 | MP0003195_calcinosis | 0.58073484 |
| 105 | MP0001958_emphysema | 0.57996987 |
| 106 | MP0000490_abnormal_crypts_of | 0.56963923 |
| 107 | MP0000465_gastrointestinal_hemorrhage | 0.56936024 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.56795291 |
| 109 | MP0000609_abnormal_liver_physiology | 0.55991661 |
| 110 | MP0000627_abnormal_mammary_gland | 0.55958847 |
| 111 | MP0003795_abnormal_bone_structure | 0.54433691 |
| 112 | MP0002019_abnormal_tumor_incidence | 0.53633062 |
| 113 | MP0005319_abnormal_enzyme/_coenzyme | 0.53411055 |
| 114 | MP0003329_amyloid_beta_deposits | 0.52930880 |
| 115 | MP0002163_abnormal_gland_morphology | 0.52725761 |
| 116 | MP0005381_digestive/alimentary_phenotyp | 0.51957075 |
| 117 | MP0000371_diluted_coat_color | 0.51933559 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.51346066 |
| 119 | MP0001216_abnormal_epidermal_layer | 0.49330317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.30688743 |
| 2 | Chronic otitis media (HP:0000389) | 6.08734667 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.99803772 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.79936541 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.52654121 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 4.98748529 |
| 7 | Nasal polyposis (HP:0100582) | 4.72085873 |
| 8 | Myositis (HP:0100614) | 4.68866207 |
| 9 | Increased IgM level (HP:0003496) | 4.64202495 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.61521521 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.49627583 |
| 12 | Abnormality of the nasal mucosa (HP:0000433) | 4.49566294 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.28192272 |
| 14 | Orchitis (HP:0100796) | 4.25580479 |
| 15 | Recurrent bronchitis (HP:0002837) | 4.11629397 |
| 16 | Recurrent viral infections (HP:0004429) | 4.04389275 |
| 17 | Stomatitis (HP:0010280) | 4.03256038 |
| 18 | Recurrent fungal infections (HP:0002841) | 4.02873864 |
| 19 | Vasculitis (HP:0002633) | 3.97020003 |
| 20 | Recurrent skin infections (HP:0001581) | 3.87582421 |
| 21 | Optic neuritis (HP:0100653) | 3.84648635 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 3.84648635 |
| 23 | Basal ganglia calcification (HP:0002135) | 3.78758074 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 3.65774947 |
| 25 | Encephalitis (HP:0002383) | 3.57141936 |
| 26 | Chronic sinusitis (HP:0011109) | 3.52472464 |
| 27 | Hypergammaglobulinemia (HP:0010702) | 3.43276856 |
| 28 | Gastrointestinal infarctions (HP:0005244) | 3.41063964 |
| 29 | Recurrent cutaneous fungal infections (HP:0011370) | 3.38320931 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.38320931 |
| 31 | Pustule (HP:0200039) | 3.34872995 |
| 32 | Interstitial pulmonary disease (HP:0006530) | 3.33822186 |
| 33 | Gingivitis (HP:0000230) | 3.31161647 |
| 34 | Abnormality of T cell number (HP:0011839) | 3.30317751 |
| 35 | Thick nail (HP:0001805) | 3.28474571 |
| 36 | Obstructive lung disease (HP:0006536) | 3.07203753 |
| 37 | Chronic obstructive pulmonary disease (HP:0006510) | 3.07203753 |
| 38 | Autoimmune hemolytic anemia (HP:0001890) | 3.06412635 |
| 39 | Porencephaly (HP:0002132) | 3.03954732 |
| 40 | T lymphocytopenia (HP:0005403) | 3.00751130 |
| 41 | Cellulitis (HP:0100658) | 2.99958362 |
| 42 | Hemoptysis (HP:0002105) | 2.98013660 |
| 43 | Abnormality of glycolipid metabolism (HP:0010969) | 2.97544873 |
| 44 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.97544873 |
| 45 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.97544873 |
| 46 | Pulmonary infiltrates (HP:0002113) | 2.96053037 |
| 47 | Periodontitis (HP:0000704) | 2.95146713 |
| 48 | Abnormality of T cells (HP:0002843) | 2.90305373 |
| 49 | Increased cerebral lipofuscin (HP:0011813) | 2.86465977 |
| 50 | Tetraparesis (HP:0002273) | 2.84378172 |
| 51 | Pulmonary embolism (HP:0002204) | 2.80356520 |
| 52 | Spontaneous hematomas (HP:0007420) | 2.75113168 |
| 53 | Arterial thrombosis (HP:0004420) | 2.74774980 |
| 54 | Vacuolated lymphocytes (HP:0001922) | 2.70349395 |
| 55 | Abnormality of T cell physiology (HP:0011840) | 2.67721366 |
| 56 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.63107635 |
| 57 | Gingival bleeding (HP:0000225) | 2.61708557 |
| 58 | Leukocytosis (HP:0001974) | 2.61021967 |
| 59 | Hematochezia (HP:0002573) | 2.58640209 |
| 60 | Meningitis (HP:0001287) | 2.56906448 |
| 61 | Prostate neoplasm (HP:0100787) | 2.54437336 |
| 62 | Emphysema (HP:0002097) | 2.52074835 |
| 63 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.49903555 |
| 64 | Thrombocytosis (HP:0001894) | 2.49360639 |
| 65 | Keratoconjunctivitis sicca (HP:0001097) | 2.47963883 |
| 66 | Increased IgE level (HP:0003212) | 2.47677526 |
| 67 | Urticaria (HP:0001025) | 2.44735966 |
| 68 | Joint swelling (HP:0001386) | 2.43579184 |
| 69 | Amyloidosis (HP:0011034) | 2.42564610 |
| 70 | IgA deficiency (HP:0002720) | 2.42221242 |
| 71 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.40412893 |
| 72 | Chronic diarrhea (HP:0002028) | 2.39947532 |
| 73 | Skin ulcer (HP:0200042) | 2.38572727 |
| 74 | Chest pain (HP:0100749) | 2.37626092 |
| 75 | Episodic fever (HP:0001954) | 2.31792963 |
| 76 | IgG deficiency (HP:0004315) | 2.31150174 |
| 77 | Glomerulopathy (HP:0100820) | 2.28885544 |
| 78 | Premature loss of primary teeth (HP:0006323) | 2.28606223 |
| 79 | Loss of speech (HP:0002371) | 2.27812826 |
| 80 | Myocardial infarction (HP:0001658) | 2.26919854 |
| 81 | Gastrointestinal inflammation (HP:0004386) | 2.26140462 |
| 82 | Osteolytic defects of the hand bones (HP:0009699) | 2.25337357 |
| 83 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.25337357 |
| 84 | Bronchitis (HP:0012387) | 2.25245946 |
| 85 | Colitis (HP:0002583) | 2.25002354 |
| 86 | Keratoconjunctivitis (HP:0001096) | 2.24152425 |
| 87 | Eosinophilia (HP:0001880) | 2.22145281 |
| 88 | Peritonitis (HP:0002586) | 2.19921734 |
| 89 | Polyneuropathy (HP:0001271) | 2.18700184 |
| 90 | Osteomyelitis (HP:0002754) | 2.18615053 |
| 91 | Prolonged bleeding time (HP:0003010) | 2.18488325 |
| 92 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.17256488 |
| 93 | Petechiae (HP:0000967) | 2.15890403 |
| 94 | Anorexia (HP:0002039) | 2.14133785 |
| 95 | Gangrene (HP:0100758) | 2.13438275 |
| 96 | Keratitis (HP:0000491) | 2.13048667 |
| 97 | Lymphopenia (HP:0001888) | 2.12803904 |
| 98 | Increased serum ferritin (HP:0003281) | 2.12138782 |
| 99 | Dysostosis multiplex (HP:0000943) | 2.12103110 |
| 100 | Abnormality of the endocardium (HP:0004306) | 2.11386104 |
| 101 | Acne (HP:0001061) | 2.11146075 |
| 102 | Granulocytopenia (HP:0001913) | 2.09962041 |
| 103 | Recurrent pneumonia (HP:0006532) | 2.09203718 |
| 104 | Vertigo (HP:0002321) | 2.09130643 |
| 105 | Purpura (HP:0000979) | 2.09080093 |
| 106 | Recurrent lower respiratory tract infections (HP:0002783) | 2.08528910 |
| 107 | Abnormality of the pericardium (HP:0001697) | 2.08422171 |
| 108 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.06569012 |
| 109 | Arthralgia (HP:0002829) | 2.06454672 |
| 110 | Abnormality of the pleura (HP:0002103) | 2.05849786 |
| 111 | Hepatosplenomegaly (HP:0001433) | 2.05521436 |
| 112 | Axonal loss (HP:0003447) | 2.04070394 |
| 113 | Disinhibition (HP:0000734) | 2.03546112 |
| 114 | Malnutrition (HP:0004395) | 2.03275107 |
| 115 | Glomerulonephritis (HP:0000099) | 2.03171173 |
| 116 | Cleft eyelid (HP:0000625) | 2.01497675 |
| 117 | Hypochromic anemia (HP:0001931) | 2.00098332 |
| 118 | Inflammation of the large intestine (HP:0002037) | 1.99231204 |
| 119 | Panhypogammaglobulinemia (HP:0003139) | 1.98927902 |
| 120 | Abnormality of the peritoneum (HP:0002585) | 1.98426097 |
| 121 | Nephritis (HP:0000123) | 1.97313614 |
| 122 | Abnormality of B cell number (HP:0010975) | 1.96236494 |
| 123 | Esophageal varix (HP:0002040) | 1.95675275 |
| 124 | Epistaxis (HP:0000421) | 1.95296837 |
| 125 | Abnormality of eosinophils (HP:0001879) | 1.94845513 |
| 126 | Thrombophlebitis (HP:0004418) | 1.94690256 |
| 127 | Acute hepatic failure (HP:0006554) | 1.94426613 |
| 128 | Slow saccadic eye movements (HP:0000514) | 1.93966335 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TYK2 | 4.35517665 |
| 2 | MAP3K14 | 4.32545673 |
| 3 | JAK3 | 3.79761775 |
| 4 | TBK1 | 3.55763250 |
| 5 | IKBKE | 3.51537447 |
| 6 | FGFR4 | 3.49582497 |
| 7 | MAP4K1 | 3.35071446 |
| 8 | BLK | 3.34988498 |
| 9 | KIT | 2.95374805 |
| 10 | JAK1 | 2.90723009 |
| 11 | TXK | 2.81073543 |
| 12 | RIPK4 | 2.53509050 |
| 13 | PBK | 2.46661163 |
| 14 | IKBKB | 2.30384176 |
| 15 | FGFR3 | 2.18834700 |
| 16 | ERN1 | 2.16455491 |
| 17 | MAP3K13 | 2.15509334 |
| 18 | IRAK4 | 2.10880818 |
| 19 | PRPF4B | 2.07511141 |
| 20 | ZAP70 | 1.99608976 |
| 21 | IRAK3 | 1.87559647 |
| 22 | PIM2 | 1.84371432 |
| 23 | CHUK | 1.62144261 |
| 24 | EPHA3 | 1.54534074 |
| 25 | GRK6 | 1.52674698 |
| 26 | EPHB1 | 1.52392889 |
| 27 | TAOK1 | 1.45907050 |
| 28 | NME2 | 1.45789442 |
| 29 | SYK | 1.41425692 |
| 30 | CSK | 1.37570622 |
| 31 | HCK | 1.32215856 |
| 32 | TAOK2 | 1.31843870 |
| 33 | LCK | 1.29376573 |
| 34 | TNK2 | 1.23665028 |
| 35 | MST4 | 1.22341697 |
| 36 | NEK9 | 1.22258158 |
| 37 | JAK2 | 1.22087765 |
| 38 | CSF1R | 1.06844370 |
| 39 | ITK | 1.06208555 |
| 40 | TEC | 1.03525811 |
| 41 | RPS6KA4 | 1.02788538 |
| 42 | BTK | 1.01973555 |
| 43 | STK10 | 1.01886964 |
| 44 | LYN | 0.98490022 |
| 45 | TGFBR2 | 0.95691054 |
| 46 | BMX | 0.94305271 |
| 47 | PIM1 | 0.87272182 |
| 48 | CDC42BPA | 0.86868569 |
| 49 | IRAK2 | 0.85227233 |
| 50 | EIF2AK2 | 0.81857508 |
| 51 | NLK | 0.80263256 |
| 52 | TIE1 | 0.78157778 |
| 53 | MAP2K6 | 0.76855500 |
| 54 | LRRK2 | 0.75685913 |
| 55 | PRKCQ | 0.75220587 |
| 56 | FGR | 0.73605721 |
| 57 | HIPK2 | 0.69781635 |
| 58 | FES | 0.68975004 |
| 59 | EGFR | 0.68116003 |
| 60 | CAMKK2 | 0.67081125 |
| 61 | TRIB3 | 0.66722286 |
| 62 | IRAK1 | 0.63858925 |
| 63 | TESK2 | 0.62338519 |
| 64 | TGFBR1 | 0.61873457 |
| 65 | RIPK1 | 0.60051080 |
| 66 | PIK3CG | 0.59697449 |
| 67 | STK4 | 0.59122279 |
| 68 | ARAF | 0.57927397 |
| 69 | MATK | 0.57291303 |
| 70 | MARK3 | 0.56672527 |
| 71 | ABL2 | 0.55996997 |
| 72 | KSR2 | 0.55432963 |
| 73 | MAPK7 | 0.55340849 |
| 74 | MARK2 | 0.55261236 |
| 75 | BMPR2 | 0.53115732 |
| 76 | MAP3K5 | 0.52427080 |
| 77 | MAP3K6 | 0.51894177 |
| 78 | ABL1 | 0.50902327 |
| 79 | CLK1 | 0.50592022 |
| 80 | KDR | 0.49490886 |
| 81 | PDPK1 | 0.49489916 |
| 82 | TAOK3 | 0.48888886 |
| 83 | DDR2 | 0.48775781 |
| 84 | MST1R | 0.46833582 |
| 85 | PTK6 | 0.45009252 |
| 86 | PRKCD | 0.44411987 |
| 87 | ACVR1B | 0.43989468 |
| 88 | SGK3 | 0.41836540 |
| 89 | TRPM7 | 0.40893735 |
| 90 | RPS6KA5 | 0.40132521 |
| 91 | MAP3K2 | 0.39573660 |
| 92 | MAPK11 | 0.39524129 |
| 93 | EEF2K | 0.39253353 |
| 94 | PDGFRB | 0.36574070 |
| 95 | MAP3K10 | 0.34909106 |
| 96 | MAP3K1 | 0.34808781 |
| 97 | PKN2 | 0.34173578 |
| 98 | TYRO3 | 0.34107097 |
| 99 | TTN | 0.33990080 |
| 100 | MOS | 0.33987632 |
| 101 | ALK | 0.33034918 |
| 102 | MAPK12 | 0.32753840 |
| 103 | PRKD2 | 0.32390997 |
| 104 | SIK2 | 0.32162935 |
| 105 | MAPKAPK2 | 0.30151584 |
| 106 | DYRK1B | 0.30139914 |
| 107 | PTK2B | 0.28691442 |
| 108 | MAP2K3 | 0.28626548 |
| 109 | MAP3K7 | 0.28461224 |
| 110 | SGK2 | 0.27840655 |
| 111 | RET | 0.27250902 |
| 112 | RPS6KC1 | 0.26915887 |
| 113 | RPS6KL1 | 0.26915887 |
| 114 | FLT3 | 0.26464658 |
| 115 | CAMKK1 | 0.25663154 |
| 116 | CDK12 | 0.25641114 |
| 117 | FYN | 0.25506319 |
| 118 | CDK6 | 0.25104045 |
| 119 | PDK1 | 0.24522803 |
| 120 | PRKCH | 0.24495671 |
| 121 | SIK3 | 0.24239937 |
| 122 | IGF1R | 0.24148647 |
| 123 | RAF1 | 0.23099480 |
| 124 | YES1 | 0.22729574 |
| 125 | MAP3K11 | 0.21245521 |
| 126 | INSR | 0.20453396 |
| 127 | SRC | 0.17360055 |
| 128 | CDK4 | 0.16550829 |
| 129 | MAP3K3 | 0.15854191 |
| 130 | STK3 | 0.15584759 |
| 131 | GRK7 | 0.15260526 |
| 132 | DAPK3 | 0.14923027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.28892211 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.21994014 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.12989772 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.07338831 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.91226361 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.81464221 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.78360860 |
| 8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.69282260 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.39286024 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.39034860 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.36941444 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.33072327 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.27924569 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 2.25229586 |
| 15 | Influenza A_Homo sapiens_hsa05164 | 2.22521700 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.16262005 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.15931728 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.12750836 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.08988079 |
| 20 | Malaria_Homo sapiens_hsa05144 | 2.07634386 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.96056903 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.92352519 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.84842682 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.83293565 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.82832267 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.75461136 |
| 27 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.70661761 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.69058558 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.63950518 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.60475285 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.50635374 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.46582624 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.46460669 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.43098399 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.43050756 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.41454647 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.40821602 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40415659 |
| 39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.37242556 |
| 40 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.27197360 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.24919747 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.19842908 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09463031 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 1.03735846 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99987034 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 0.96064068 |
| 47 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.96002019 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88455210 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87925304 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83769726 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81216447 |
| 52 | Amoebiasis_Homo sapiens_hsa05146 | 0.75305479 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72702967 |
| 54 | Prion diseases_Homo sapiens_hsa05020 | 0.72336654 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71548487 |
| 56 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.69340018 |
| 57 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67462555 |
| 58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.65428517 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.64957223 |
| 60 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63993042 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63651001 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63388520 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61199772 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59525829 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58589171 |
| 66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58048414 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.56401249 |
| 68 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55359408 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53582144 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52299398 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47565644 |
| 72 | Proteasome_Homo sapiens_hsa03050 | 0.46488613 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45115226 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44579788 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42592333 |
| 76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40181768 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.37323512 |
| 78 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.36645769 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36225935 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32544243 |
| 81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31166825 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.30200931 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.27555678 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26427858 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26060533 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.24545131 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | 0.24354245 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.24327659 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23842977 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.23806141 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.23692523 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23004426 |
| 93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.21425178 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21365999 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.18708895 |
| 96 | Prostate cancer_Homo sapiens_hsa05215 | 0.18583796 |
| 97 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.17905674 |
| 98 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.17346601 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.17058028 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.16432092 |
| 101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.16228286 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15820497 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.13971250 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.11982314 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.10306624 |
| 106 | ABC transporters_Homo sapiens_hsa02010 | 0.09733758 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.09726065 |
| 108 | Pathways in cancer_Homo sapiens_hsa05200 | 0.07430009 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.07315516 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | 0.07201481 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.06942933 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.06898771 |
| 113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.06023166 |
| 114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.05735243 |

